NASDAQ:JYNT Joint (JYNT) Stock Price, News & Analysis $8.29 -0.05 (-0.60%) Closing price 04:00 PM EasternExtended Trading$8.30 +0.01 (+0.06%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Joint Stock (NASDAQ:JYNT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Joint alerts:Sign Up Key Stats Today's Range$8.23▼$8.4150-Day Range$7.85▼$8.9152-Week Range$7.50▼$10.67Volume49,062 shsAverage Volume91,189 shsMarket Capitalization$117.22 millionP/E Ratio30.70Dividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview The Joint Corp. operates The Joint Chiropractic, a network of chiropractic clinics in the United States. The company provides routine, non-invasive chiropractic care focused on spinal health, mobility and wellness through licensed chiropractors in convenient outpatient locations. The Joint Chiropractic primarily serves patients through membership and wellness plans, as well as individual visits. Its clinics generally offer services without requiring traditional appointments, and the company supports franchisees with branding, operating systems, technology, marketing and business services. Founded in 1999 and headquartered in Scottsdale, Arizona, The Joint Corp. has expanded through a combination of franchised and company-owned clinics across the United States. The company’s operations are concentrated in the U.S. market, where it seeks to make chiropractic care more accessible through standardized clinic formats and subscription-based care options.AI Generated. May Contain Errors. Read More Joint Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks30th Percentile Overall ScoreJYNT MarketRank™: Joint scored higher than 30% of companies evaluated by MarketBeat, and ranked 684th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingReduce Consensus RatingJoint has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageJoint has only been the subject of 2 research reports in the past 90 days.Read more about Joint's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth103.23% Earnings GrowthEarnings for Joint are expected to grow by 103.23% in the coming year, from $0.31 to $0.63 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Joint is 30.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.94.Price to Earnings Ratio vs. SectorThe P/E ratio of Joint is 30.70, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.98.Price to Book Value per Share RatioJoint has a P/B Ratio of 8.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Joint's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.45% of the float of Joint has been sold short.Short Interest Ratio / Days to CoverJoint has a short interest ratio ("days to cover") of 4.89.Change versus previous monthShort interest in Joint has recently increased by 9.96%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJoint does not currently pay a dividend.Dividend GrowthJoint does not have a long track record of dividend growth. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 3 news articles for Joint this week, compared to 2 articles on an average week. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Joint insiders have not sold or bought any company stock.Percentage Held by Insiders30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Joint's insider trading history. Receive JYNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JYNT Stock News HeadlinesThe Joint Corp.(NasdaqCM:JYNT) dropped from S&P Global BMI IndexSeptember 21 at 1:04 AM | marketscreener.comMFinancial Survey: Acadia Healthcare (NASDAQ:ACHC) and Joint (NASDAQ:JYNT)September 20, 2026 | americanbankingnews.comAI Panic: Sell now or wait?Bank of America, Goldman Sachs, and Morgan Stanley have reportedly warned private clients about a coming stock market crisis. Business Insider says it could mean a brutal decade ahead for stocks, one that could keep portfolios in the red well into the 2030s. New technology may offer a way to prepare before the warning plays out.September 24 at 1:00 AM | TradeSmith (Ad)The Joint reiterates 2026 outlook while cutting new clinic openings to 22-26August 7, 2026 | seekingalpha.comThe Joint Corp. (JYNT) Q2 2026 Earnings Call TranscriptAugust 7, 2026 | seekingalpha.comThe Joint Chiropractic Earns Entrepreneur Recognition as a Premier Multi-Unit Franchise InvestmentJuly 30, 2026 | prnewswire.comThe Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and WebcastJuly 23, 2026 | globenewswire.comThe Joint Chiropractic Expands to 44th State with Opening of Rhode Island ClinicJuly 1, 2026 | prnewswire.comSee More Headlines JYNT Stock Analysis - Frequently Asked Questions How have JYNT shares performed this year? Joint's stock was trading at $8.72 at the start of the year. Since then, JYNT stock has decreased by 4.9% and is now trading at $8.29. How were Joint's earnings last quarter? The Joint Corp. (NASDAQ:JYNT) released its quarterly earnings data on Thursday, August, 6th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.00. The business earned $15.18 million during the quarter, compared to analyst estimates of $14.57 million. Joint had a net margin of 6.49% and a trailing twelve-month return on equity of 12.02%. Read the conference call transcript. Is Joint buying back stock? Joint's Board of Directors initiated a stock buyback plan on Thursday, June 5th 2025, which allows the company to repurchase $5,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 2.7% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's board believes its shares are undervalued. When did Joint IPO? Joint (JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.00-$7.00 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager. Who are Joint's major shareholders? Top institutional shareholders of Joint include BlackRock Inc. (2.02%), Squarepoint Ops LLC (0.75%), Susquehanna International Group LLP (0.31%) and Grandeur Peak Global Advisors LLC (0.30%). View institutional ownership trends. How do I buy shares of Joint? Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Joint own? Based on aggregate information from My MarketBeat watchlists, some other companies that Joint investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings8/06/2026Today9/24/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (17m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 JYNT's financial health is in the Red zone, according to TradeSmith. JYNT has been in this zone for over 17 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:JYNT CIK1612630 Webwww.thejoint.com Phone(480) 245-5960Fax480-513-7989Employees330Year Founded1999Profitability EPS (Trailing Twelve Months)$0.27 Trailing P/E Ratio30.70 Forward P/E Ratio26.74 P/E GrowthN/ANet Income$2.91 million Net Margins6.49% Pretax Margin3.61% Return on Equity12.02% Return on Assets3.47% Debt Debt-to-Equity RatioN/A Current Ratio1.83 Quick Ratio1.83 Sales & Book Value Annual Sales$54.90 million Price / Sales2.14 Cash Flow$0.10 per share Price / Cash Flow86.15 Book Value$1.01 per share Price / Book8.21Miscellaneous Outstanding Shares14,140,000Free Float9,872,000Market Cap$117.22 million OptionableOptionable Beta1.05 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:JYNT) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Joint With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
